Scientists test 'Living Drug' to fight advanced cancers
Disease control
Recruiting now
This is a very early-stage study testing a new type of personalized treatment for people with advanced solid tumors. Doctors will collect a patient's own immune cells, genetically modify them to target a specific cancer mutation (KRAS G12V or G12D), and infuse them back into the …
Phase: PHASE1 • Sponsor: TingBo Liang • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC